Milestone Scientific (NYSE:MLSS) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.89 million.
Milestone Scientific (NYSE:MLSS) reported Q2 EPS of ($0.04), $0.01 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.89 million.